974
Views
11
CrossRef citations to date
0
Altmetric
Miscellaneous

Osteoclastic resorptive capacity is suppressed in patients receiving hyperbaric oxygen therapy

, &
Pages 264-269 | Received 10 Jan 2014, Accepted 23 Jan 2014, Published online: 19 Sep 2014

  • Al Hadi H, Smerdon GR, Fox SW. Hyperbaric oxygen therapy suppresses osteoclast formation and bone resorption. J Orthop Res 2013; 31 (11): 1839-44.
  • Arnett TR, Gibbons DC, Utting JC, Orriss IR, Hoebertz A, Rosendaal M, et al. Hypoxia is a major stimulator of osteoclast formation and bone resorption. J Cell Physiol 2003; 196 (1): 2-8.
  • Benson RM, Minter LM, Osborne BA, Granowitz EV. Hyperbaric oxygen inhibits stimulus-induced proinflammatory cytokine synthesis by human blood-derived monocyte-macrophages. Clin Exp Immunol 2003; 134: 57-62.
  • Burstone MS. Histochemical demonstration of acid phosphatases with naphthol AS-phosphates. J Natl Cancer I 1958; 21: 523-39.
  • Fox SW, Fuller K, Bayley KE, Lean JM, Chambers TJ. TGF-ß1 and IFN-g direct macrophage activation by TNF-a to osteoclastic or cytocidal phenotype. J Immunol 2000; 165 (9): 4957-63.
  • Fuller K, Murphy C, Kirstein B, Fox SW, Chambers TJ. TNFa potently activates osteoclasts, through a direct action independent of and strongly synergistic with RANKL. Endocrinology 2002; 143 (3): 1108-18.
  • Gill AL, Bell C NA. Hyperbaric oxygen: its uses, mechanisms of action and outcomes. Q J Med 2004; 97 (7): 385-95.
  • Goldman RJ. Hyperbaric oxygen therapy for wound healing and limb salvage: A systematic review. PM&R 2009; 1 (5): 471-89.
  • Jacome-Galarza CE, Lee SK, Lorenzo JA, Aguila HL. Identification, characterization, and isolation of a common progenitor for osteoclasts, macrophages, and dendritic cells from murine bone marrow and periphery. J Bone Miner Res 2013; 28 (5): 1203-13.
  • Jacquin C, Gran DE, Lee SK, Lorenzo JA, Aguila HL. Identification of multiple osteoclast precursor populations in murine bone marrow. J Bone Miner Res 2006; 21 (1): 67-77.
  • Kudchodkar B, Jones H, Simecka J, Dory L. Hyperbaric oxygen treatment attenuates the pro-inflammatory and immune responses in apolipoprotein E knockout mice. Clin Immunol 2008; 128 (3): 435-41.
  • Muhonen A, Haaparanta M, Grönroos T, Bergman J, Knuuti J, Hinkka S, et al. Osteoblastic activity and neoangiogenesis in distracted bone of irradiated rabbit mandible with or without hyperbaric oxygen treatment. Int J Oral Maxillofac Surg 2004; 33 (2): 173-8.
  • Pasquier D, Hoelscher T, Schmutz J, Dische S, Mathieu D, Baumann M, et al. Hyperbaric oxygen therapy in the treatment of radio-induced lesions in normal tissues: a literature review. Radiother Oncol 2004; 72 (1): 1-13.
  • Pitak-Arnnop P, Sader R, Dhanuthai K, Masaratana P, Bertolus C, Chaine A, et al. Management of osteoradionecrosis of the jaws: An analysis of evidence. Eur J Surg Oncol 2008; 34: 1123-34.
  • . Reale M, Di Giulio C, Cacchio M, Barbacane RC, Grilli A, Felaco M, et al. Oxygen supply modulates MCP-1 release in monocytes from young and aged rats: decrease of MCP-1 transcription and translation is age-related. Mol Cell Biochem 2003; 248 (1-2): 1-6.
  • Tibbles PM, Edelsberg JS. Hyperbaric-oxygen therapy. N Engl J Med 1996; 334 (25): 1642-8.
  • Utting JC, Robins SP, Brandao-Burch A, Orriss IR, Behar J, Arnett TR. Hypoxia inhibits the growth, differentiation and bone-forming capacity of rat osteoblasts. Exp Cell Res 2006; 312 (10): 1693-702.
  • van den Blink B, van der Kleij AJ, Versteeg HH, Peppelenbosch MP. Immunomodulatory effect of oxygen and pressure. Comparative biochemistry and physiology Part A. Mol Integr Phys 2002; 132 (1): 193-7.
  • Wu D, Malda J, Crawford R, Xiao Y. Effects of hyperbaric oxygen on proliferation and differentiation of osteoblasts from human alveolar bone. Conn Tiss Res 2007; 48: 206-13.